Log in

OTCMKTS:GNGBYGETINGE AB/ADR Stock Price, Forecast & News

$17.93
-0.18 (-0.99 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.93
Now: $17.93
$18.06
50-Day Range
$17.15
MA: $18.31
$19.22
52-Week Range
$13.20
Now: $17.93
$19.63
Volume2,837 shs
Average Volume1,607 shs
Market Capitalization$4.56 billion
P/E Ratio38.15
Dividend Yield0.61%
Beta0.74
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GNGBY
CUSIPN/A
CIKN/A
Phone46-1-033-500-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.81 billion
Cash Flow$1.59 per share
Book Value$8.15 per share

Profitability

Net Income$129.29 million

Miscellaneous

Employees12,000
Market Cap$4.56 billion
Next Earnings Date6/9/2020 (Estimated)
OptionableNot Optionable

Receive GNGBY News and Ratings via Email

Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter.

GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions

How has GETINGE AB/ADR's stock been impacted by COVID-19 (Coronavirus)?

GETINGE AB/ADR's stock was trading at $16.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GNGBY stock has increased by 10.1% and is now trading at $17.93. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of GETINGE AB/ADR?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GETINGE AB/ADR in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for GETINGE AB/ADR.

When is GETINGE AB/ADR's next earnings date?

GETINGE AB/ADR is scheduled to release its next quarterly earnings announcement on Tuesday, June 9th 2020. View our earnings forecast for GETINGE AB/ADR.

Has GETINGE AB/ADR been receiving favorable news coverage?

Media coverage about GNGBY stock has trended neutral this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. GETINGE AB/ADR earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news aboutGETINGE AB/ADR.

Who are some of GETINGE AB/ADR's key competitors?

Who are GETINGE AB/ADR's key executives?

GETINGE AB/ADR's management team includes the following people:
  • Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 47)
  • Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 47)
  • Lars Mattson, Head of Investor Relations
  • Ms. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 54)
  • Mr. Abraham Ronai, Gen. Counsel

What is GETINGE AB/ADR's stock symbol?

GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY."

How do I buy shares of GETINGE AB/ADR?

Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GETINGE AB/ADR's stock price today?

One share of GNGBY stock can currently be purchased for approximately $17.93.

How big of a company is GETINGE AB/ADR?

GETINGE AB/ADR has a market capitalization of $4.56 billion and generates $2.81 billion in revenue each year. GETINGE AB/ADR employs 12,000 workers across the globe.

What is GETINGE AB/ADR's official website?

The official website for GETINGE AB/ADR is www.getinge.com.

How can I contact GETINGE AB/ADR?

GETINGE AB/ADR's mailing address is LINDHOLMSPIREN 7, GOTHENBURG V7, 417 56. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.